Sectra Expands AI Offerings to Include Pathology Through New Partnership

In a significant development for healthcare technology, Sectra, a leading international company specializing in medical imaging IT and cybersecurity, has announced a strategic distribution agreement with Paige.AI, a vendor renowned for its innovative pathology AI applications. This partnership signals the introduction of Paige’s advanced AI solutions into Sectra's service portfolio, marking a pivotal step towards enhancing diagnostic capabilities in pathology alongside existing offerings in radiology and cardiology.

The collaboration allows Sectra to provide its clients with the first pathology AI applications under a unified contract, featuring an integrated hosting solution and a single vendor for seamless implementation, integration, and ongoing support. This initiative is part of Sectra's broader commitment to improve healthcare delivery by streamlining diagnostic pathways for critical conditions such as cancer.

Nynke Breimer, Global Product Manager for Amplifier Services, expressed enthusiasm about the agreement, stating, "By uniting these diverse imaging modalities, we empower healthcare professionals to enhance collaboration across key specialties such as radiology, pathology, and genomics. This integration is vital for optimizing cancer diagnostics as it enables better communication and workflow efficiency among various disciplines."

One of the immediate projects stemming from this partnership is a proof-of-concept program initiated with Region Skåne, a prominent healthcare provider in Sweden. This project aims to assess the effectiveness of the Paige Prostate Suite in enhancing their existing pathology workflows. By incorporating AI into their diagnostic processes, pathologists will benefit from automated analysis and reporting, thus improving overall accuracy and efficiency while freeing up valuable time for healthcare practitioners.

Kevin Sandeman, Head of Digital Pathology Development at Region Skåne, discussed the rationale behind selecting prostate cancer for this pilot, highlighting its prevalence and structured workflow: "The prostate cancer diagnosis landscape is marked by high volumes and a variety of CE-marked AI tools, making it an optimal candidate for our proof-of-concept. This allows us to explore real-world applications of AI while contributing to a national framework that ensures the safe and effective use of AI in cancer diagnostics."

Furthermore, the newly implemented Sectra Amplifier Service will furnish a fully managed AI platform through the cloud. This service streamlines the entire workflow for healthcare providers by covering everything from integration and deployment to hosting and support. Such a holistic approach diminishes the burden on IT departments while also diminishing the risks associated with managing disparate systems, thus enhancing cybersecurity measures across healthcare facilities.

Sectra's partnership with Paige marks a significant milestone, as it showcases the potential of AI in transforming pathology practices. The agreement, which took effect in March 2025, positions Sectra as a reseller of the Paige Prostate Suite, reinforcing its commitment to offering comprehensive and unified AI healthcare solutions.

In an era where the healthcare landscape is rapidly evolving, the incorporation of AI into clinical practices stands to revolutionize how patient care is delivered. Sectra's initiative not only promotes operational efficiency but is also designed to enable healthcare providers to scale their services as needed without the hassles of migrating to new back-end systems. This kind of flexibility is essential in the contemporary healthcare environment where adaptability is key to success.

With the backing of a robust enterprise imaging solution, Sectra's model for integrating all imaging needs into one cohesive system promises to deliver improved outcomes while simultaneously lowering operational costs. This strategic move is likely to set a precedent as healthcare organizations worldwide look for cost-effective ways to leverage technology to enhance patient services and streamline diagnostics.

About Sectra

Sectra has been a pioneer in providing IT solutions for healthcare since its inception in 1978. Based in Linköping, Sweden, the company operates internationally, boasting sales operations in 19 countries and partnerships around the globe. Sectra's unwavering focus is on improving healthcare efficiency while securing sensitive information for authorities and defense forces across Europe. In the fiscal year 2023/2024, Sectra reported sales amounting to SEK 2,964 million, firmly establishing its position on the Nasdaq Stockholm exchange.

For additional details or inquiries, interested parties are encouraged to reach out to Dr. Torbjörn Kronander or Marie Ekström Trägårdh at Sectra's headquarters.